Study Summary
This trial will study the effects of epinephrine on the body, specifically how it regulates function and inflammation.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: From baseline (pre glucose clamp) to end of experiment (time 240 minutes- 2 hours post intervention (glucose clamp))
Trial Safety
Phase-Based Safety
Side Effects for
Awards & Highlights
Trial Design
4 Treatment Groups
Epinephrine infusion-0.015ug/kg/min
1 of 4
Epinephrine infusion-0.03 ug/kg/min
1 of 4
Epinephrine infusion-0.06 ug/kg/min
1 of 4
Saline infusion
1 of 4
Experimental Treatment
Non-Treatment Group
32 Total Participants · 4 Treatment Groups
Primary Treatment: Epinephrine · Has Placebo Group · Phase < 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 55 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
For what purpose is Epinephrine typically employed?
"Epinephrine can be used to treat low blood pressure, an unresponsive slow heart rate, and an abnormal dilation of the pupil." - Anonymous Online Contributor
Are there any open enrollment opportunities for this research project?
"If you consult clinicaltrials.gov, you'll see that this study is still looking for participants. It was originally posted on June 1st, 2016 but was updated most recently on April 8th, 2022." - Anonymous Online Contributor
What is the precedent for Epinephrine clinical trials?
"As of right now, there are 33 on-going Epinephrine trials with 5 in the final Phase 3. A majority of these studies are centred in Baltimore, Maryland, but there are 52 locations in total running these Epinephrine trials." - Anonymous Online Contributor
If a potential test subject is younger than 65, will they still be able to participate in this experiment?
"The age range for people who can enroll in this trial are those who are 18 years old or older, but younger than 55 years old." - Anonymous Online Contributor